1. A phase I/II study of JX-594 oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer. (October 2020) Authors: Monge, C.; Xie, C.; Brar, G.; Akoth, E.; Webb, S.; Mabry, D.; Redd, B.; Levy, E.; Wood, B.; Greten, T. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗